DEVELOPMENT AND COMMERCIALIZATION FUNDING AGREEMENTDevelopment and Commercialization Funding Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThis Development and Commercialization Funding Agreement (“Agreement”), made effective as of June 10, 2020 (the “Effective Date”), is by and between Reata Pharmaceuticals Inc., a Delaware corporation (“Reata”), and BXLS V – River L.P. (together with its successors and assigns, “BXLS”), a limited partnership organized and existing under the laws of Delaware (each, a “Party” and collectively, the “Parties”).
COMMON STOCK PURCHASE AGREEMENT BY AND BETWEEN REATA PHARMACEUTICALS, INC. ANDCommon Stock Purchase Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2020 Company IndustryThis COMMON STOCK PURCHASE AGREEMENT, dated as of June 10, 2020 (this “Agreement”), is entered into by and between REATA PHARMACEUTICALS, INC., a Delaware corporation (“Reata”), BXLS V – River L.P., (“BXLS V”), a limited partnership organized and existing under the laws of Delaware, and BXLS Family Investment Partnership (CYM) V – ESC L.P., a limited partnership organized and existing under the laws of Delaware (together with BXLS V, collectively, “BXLS” and each, a “BXLS Entity”) (each, a “Party” and collectively, the “Parties”).
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • August 10th, 2020 • Reata Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledAugust 10th, 2020 Company IndustryTHIS FIRST AMENDMENT TO LEASE AGREEMENT (this “Amendment”) is made and entered into as of this 27 day of May, 2020, by and between TC LEGACY PHASE I VENTURE, LLC, a Delaware limited liability company (“Landlord”), and REATA PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).